Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Allison M. Winter, Olivia Landever, Hiruni Mendries, Willem Van Heeckeren, Chieh-Lin Fu, Robert M. Dean, Taylor R. Brooks, Deepa Jagadeesh, Paolo F. Caimi, Brian T. Hill

Blood (2024) 144 (Supplement 1): 3247.

https://doi.org/10.1182/blood-2024-200306

Published: 2024

Journal Articles

Pomalidomide Induces Myeloma Cell Death Via GPX4-Mediated Ferroptosis

Yin-Che Wang, Chieh-Lin Jerry Teng, Yu-Min Liao

Blood (2024) 144 (Supplement 1): 6837.

https://doi.org/10.1182/blood-2024-193750

Published: 2024

Journal Articles

Doxorubicin Synergizes Bortezomib-Induced Multiple Myeloma Cell Death By Inhibiting Aggresome Formation Leading to ER Stress and Apoptosis

Yin-Che Wang, Yu-Min Liao, Chieh-Lin Jerry Teng

Blood (2024) 144 (Supplement 1): 6810.

https://doi.org/10.1182/blood-2024-194605

Published: 2024

Journal Articles

Real-World Treatment Patterns and Outcomes of Solitary Plasmacytoma in the United States: A National Cancer Database (NCDB) Analysis of Years 2004-2020

Ludovic Saba, Chieh-Lin Fu, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, John Greskovich, Jr., Chakra Pani Chaulagain

Blood (2023) 142 (Supplement 1): 2025.

https://doi.org/10.1182/blood-2023-181057

Published: 2023

Journal Articles

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Robert M. Dean, Deepa Jagadeesh, Kasra Karamlou, Chieh-Lin Fu, Allison Winter, Ethan Krauspe, Jonathan Zhou, Taylor R. Brooks, Merve Kacar, Ben K. Tomlinson, Brenda W Cooper, Hong Li, Xuefei Jia, Yanwen Chen, Jenna Thomas, Paolo F. Caimi

Blood (2023) 142 (Supplement 1): 3087.

https://doi.org/10.1182/blood-2023-173943

Published: 2023

Journal Articles

No Survival Disparity between Black and White Patient's with Stage I/II Diffuse Large B-Cell Lymphoma and It's Significance

Sindu Iska, Ludovic Saba, Hong Liang, Barbara Geraldine Dominguez, Chakra Pani Chaulagain, Chieh-Lin Fu

Blood (2023) 142 (Supplement 1): 2408.

https://doi.org/10.1182/blood-2023-172785

Published: 2023

Journal Articles

Chemotherapy Refusal Patterns in Multiple Myeloma Patients: An in-Depth Analysis of the NCDB Data from 2004 to 2020

Ludovic Saba, Chieh-Lin Fu, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, Chakra Pani Chaulagain

Blood (2023) 142 (Supplement 1): 4697.

https://doi.org/10.1182/blood-2023-181158

Published: 2023

Journal Articles

Exploring Autologous Hematopoietic Stem Cell Transplantation (HSCT) Utilization and HSCT Refusal Trends in Multiple Myeloma Patients: A Comprehensive Examination of NCDB Data from 2004 to 2020

Chakra Pani Chaulagain, Ludovic Saba, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, Chieh-Lin Fu

Blood (2023) 142 (Supplement 1): 532.

https://doi.org/10.1182/blood-2023-182051

Published: 2023

Journal Articles

MPO and Trh within Leukemia Stem Cells Increased Chemosensitivity in Acute Myeloid Leukemia: A Single-Cell RNA Sequencing Approach

Chieh-Lin Jerry Teng, Chung-Hsing Chen, Tzu‐Hung Hsiao, Ting-Shuan Wu, Yu-Min Liao

Blood (2023) 142 (Supplement 1): 4323.

https://doi.org/10.1182/blood-2023-174175

Published: 2023

Journal Articles

Determinants of Overall Survival (OS) of Waldenstrom Macroglobulinemia (WM): A National Cancer Database (NCDB) Analysis of over 14,000 Patients Treated between Years 2004 and 2017

Chakra P Chaulagain, Kevin Landau, Hong Liang, Chieh-Lin Fu

Blood (2022) 140 (Supplement 1): 9333–9334.

https://doi.org/10.1182/blood-2022-159043

Published: 2022

Journal Articles

Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma

Chakra P Chaulagain, Maroun Bou Zerdan, Jack Khouri, Beth M. Faiman, Faiz Anwer, Chieh-Lin Fu, Jason Valent

Blood (2022) 140 (Supplement 1): 12530–12531.

https://doi.org/10.1182/blood-2022-157865

Published: 2022

Journal Articles

Characteristics and Treatment Response of Newly Diagnosed Advanced-Stage and Relapsed/Refractory Hodgkin Lymphoma in Taiwan: A Nationwide Retrospective Study

Chieh-Lin Jerry Teng, Tran-Der Tan, MD, Yu-Wen Lin, Pei-Wen Lien, Hsin-Chun Chou, Fang-Ju Lin

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-141186

Published: 2020

Journal Articles

Niemann-Pick disease with isolated leukemic nonnodal mantle cell lymphoma of the spleen

Chieh Lin Fu, Maria Julia Diacovo

Blood (2020) 135 (10): 778.

https://doi.org/10.1182/blood.2019003479

Published: 2020

Journal Articles

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Yi-Jiun Su, MD, Ming-Chung Kuo, MD, Chieh-Lin Teng, MD, Tsai-Yun Chen, MD, Ming-Chun Ma, MD, Pei-Ching Hsiao, MD, Ming-Chung Wang, MD, Tung-Huei Lin, MS, Wen-Li Hwang, MD, Chih-Cheng Chen, MD, Youngsen Yang, MD, Sung-Nan Pei, MD, Yen-Min Huang, MD, Sin-Syue Li, MD, Ming-Yang Lee, MD, Hung-I Cheng, MD, Lee-Yung Shih, MD

Blood (2017) 130 (Supplement 1): 1603.

https://doi.org/10.1182/blood.V130.Suppl_1.1603.1603

Published: 2017

Journal Articles

RNA-Seq Revealed an Integration of Multiple Resistance Functions for Predicting Response to the "7+3" Induction Chemotherapy of De Novo Acute Myeloid Leukemia

Yu-Chiao Chiu, PhD, Tzu-Chieh Ho, PhD, Jia-Rong Tsai, Li-Ju Wang, MS, Shih-Lan Hsu, PhD, Yidong Chen, PhD, Chieh-Lin Teng, MD, Tzu-Hung Hsiao, PhD

Blood (2017) 130 (Supplement 1): 2485.

https://doi.org/10.1182/blood.V130.Suppl_1.2485.2485

Published: 2017

Journal Articles

CD14 Mediates Phagocytic Activity during the Granulocytic Differentiation Process in Acute Promyelocytic Leukemia Cells

Hui-Chi Hsu, MD, Wen-Hui Tsai, PhD, Yu-Chieh Lin, MA

Blood (2014) 124 (21): 4955.

https://doi.org/10.1182/blood.V124.21.4955.4955

Published: 2014

Journal Articles

Assessment of Safety and Efficacy of a New Intravenous Immunoglobulin (IGIV3I 10% Grifols) In Subjects with Chronic Immune Thrombocytopenia

Blood (2010) 116 (21): 4669.

https://doi.org/10.1182/blood.V116.21.4669.4669

Published: 2010

Journal Articles

Prognostic Value of Early 18fluorodeoxyglucose PET Scan in Patients with Diffuse Large B Cell Lymphoma Treated with Rituximab Plus CHOP or High-Dose CHOP.

Jehan Dupuis, Emmanuel Itti, Christophe Fruchart, Stéphane Bardet, Alain Rahmouni, Jean-Pierre Vilque, Chieh Lin, Karim Belhadj, Taoufik El Gnaoui, Frédérique Kuhnowski, Michel Meignan, Corinne Haioun

Blood (2008) 112 (11): 2006.

https://doi.org/10.1182/blood.V112.11.2006.2006

Published: 2008

Journal Articles

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli, Antonio M. Risitano, Hubert Schrezenmeier, Jörg Schubert, Anna Gaya, Luke Coyle, Carlos de Castro, Chieh-Lin Fu, Jaroslaw P. Maciejewski, Monica Bessler, Henk-André Kroon, Russell P. Rother, Peter Hillmen

Blood (2008) 111 (4): 1840–1847.

https://doi.org/10.1182/blood-2007-06-094136

Published: 2008

Journal Articles

High Incidence of Progression to Chronic Renal Insufficiency in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Peter Hillmen, MB, ChB, Modupe O. Elebute, MD, Richard Kelly, MD, Alvaro Urbano-Ispizua, MD, Russell P. Rother, PhD, Chieh-Lin Fu, MD, Paul Browne, MB

Blood (2007) 110 (11): 3678.

https://doi.org/10.1182/blood.V110.11.3678.3678

Published: 2007

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Pomalidomide Induces Myeloma Cell Death Via GPX4-Mediated Ferroptosis

Doxorubicin Synergizes Bortezomib-Induced Multiple Myeloma Cell Death By Inhibiting Aggresome Formation Leading to ER Stress and Apoptosis

Real-World Treatment Patterns and Outcomes of Solitary Plasmacytoma in the United States: A National Cancer Database (NCDB) Analysis of Years 2004-2020

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

No Survival Disparity between Black and White Patient's with Stage I/II Diffuse Large B-Cell Lymphoma and It's Significance

Chemotherapy Refusal Patterns in Multiple Myeloma Patients: An in-Depth Analysis of the NCDB Data from 2004 to 2020

Exploring Autologous Hematopoietic Stem Cell Transplantation (HSCT) Utilization and HSCT Refusal Trends in Multiple Myeloma Patients: A Comprehensive Examination of NCDB Data from 2004 to 2020

MPO and Trh within Leukemia Stem Cells Increased Chemosensitivity in Acute Myeloid Leukemia: A Single-Cell RNA Sequencing Approach

Determinants of Overall Survival (OS) of Waldenstrom Macroglobulinemia (WM): A National Cancer Database (NCDB) Analysis of over 14,000 Patients Treated between Years 2004 and 2017

Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma

Characteristics and Treatment Response of Newly Diagnosed Advanced-Stage and Relapsed/Refractory Hodgkin Lymphoma in Taiwan: A Nationwide Retrospective Study

Niemann-Pick disease with isolated leukemic nonnodal mantle cell lymphoma of the spleen

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

RNA-Seq Revealed an Integration of Multiple Resistance Functions for Predicting Response to the "7+3" Induction Chemotherapy of De Novo Acute Myeloid Leukemia

CD14 Mediates Phagocytic Activity during the Granulocytic Differentiation Process in Acute Promyelocytic Leukemia Cells

Assessment of Safety and Efficacy of a New Intravenous Immunoglobulin (IGIV3I 10% Grifols) In Subjects with Chronic Immune Thrombocytopenia

Prognostic Value of Early 18fluorodeoxyglucose PET Scan in Patients with Diffuse Large B Cell Lymphoma Treated with Rituximab Plus CHOP or High-Dose CHOP.

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

High Incidence of Progression to Chronic Renal Insufficiency in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only